|
|
||||||||
1 Veterans Affairs Medical Center, Minneapolis 55417; 2 Department of Biochemistry, University of Minnesota, Minneapolis, Minnesota 55455; and 3 Department of Anesthesia, Henry Ford Hospital, Detroit, Michigan 48202
| |
ABSTRACT |
|---|
|
|
|---|
Repetitive myocardial ischemia increases glucose uptake, but the effect on glycogen is unclear. Thirteen swine instrumented with a hydraulic occluder on the circumflex (Cx) artery underwent 10-min occlusions twice per day for 4 days. After 24 h postfinal ischemia and in the fasted state, echocardiogram and positron emission tomography imaging for blood flow ([13N]-ammonia) and 2-[18F]fluoro-2-deoxy-D-glucose (FDG) uptake were obtained. Tissue was then collected for ATP, creatine phosphate (CP), glycogen, and glucose transporter-4 content, and hexokinase activity. After reperfusion, regional function and CP-to-ATP ratios in the Cx and remote regions were similar. Despite the absence of stunning, the Cx region demonstrated higher glycogen levels (33 ± 11 vs. 24 ± 11 µmol/g; P < 0.05), and this increase correlated well with the increase in FDG uptake (r2 = 0.78; P < 0.01). Hexokinase activity was also increased relative to remote regions (0.62 ± 0.29 vs. 0.37 ± 0.19 IU/g; P < 0.05), with no difference in GLUT-4 content. In summary, 24 h after repetitive ischemia, glucose uptake and glycogen levels are increased at a time that functional and bioenergetic markers of stunning have recovered. The significant correlation between glycogen content and FDG accumulation in the postischemic region suggests that increased rates of glucose transport and/or phosphorylation are linked to increased glycogen levels in hearts subjected to repetitive bouts of ischemia.
myocardial ischemia; stunning; glucose transporter-4; 2-[18F]fluoro-2-deoxy-D-glucose; hexokinase
| |
INTRODUCTION |
|---|
|
|
|---|
A SINGLE EPISODE OF PROLONGED regional myocardial ischemia with reperfusion results in a sustained decrease in function and increase in glucose metabolism. The increase in glucose uptake 24 h after stunning follows nonoxidative pathways and is associated with incomplete recovery of glycogen (25, 34). Along with other indexes of metabolic abnormalities, however, normalization occurs within 1-3 wk in parallel with wall thickening (15, 23, 35). Unlike one episode of ischemia, repetitive ischemia with reperfusion might be expected to cause dissociation between the recovery of function and glucose metabolism. After multiple episodes of ischemia, for instance, regional function normalizes earlier as a result of "preconditioning against stunning" (37), whereas glucose uptake might remain elevated as a result of increased expression of the glucose transporters (GLUT) and/or hexokinase (8, 38). Such a sustained increase in the rate of glucose uptake could, in turn, be an important determinant of glycogen storage, as observed in myocardium from patients subjected to chronic ischemia (6) and skeletal muscle from rats exposed to chronic exercise training (28).
The primary objective of this study was to determine whether a glycogen overshoot occurs in repetitively ischemic-reperfused myocardium and, if increased, whether the levels correlate with a relative increase in glucose transport and/or phosphorylation. A secondary objective was to determine whether these changes are present at a time that other indexes of stunning have recovered [i.e., wall thickening and creatine phosphate (CP)-to-ATP ratios]. Positron emission tomography (PET) was used to estimate changes in myocardial glucose transport and phosphorylation with the glucose analog 2-[18F]fluoro-2-deoxy-D-glucose (FDG) during fasting conditions.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
This study was performed under the guidance of the animal care committee at the Veterans Affairs Medical Center and conformed to the National Institutes of Health Guide For the Care and Use of Laboratory Animals (NIH Publication No. 85-23, Revised 1996).
Animal Instrumentation
Domestic pigs (~30 kg) were sedated with xylazine (2 mg/kg im) and telazol (4 mg/kg im), intubated, ventilated, and anesthetized with isoflurane (1%). With the use of sterile techniques, the external jugular vein and internal carotid artery were cannulated with 7-Fr sterile catheters and subcutaneously tunneled through the neck. A left thoracotomy was performed in the fifth intercostal space, and the proximal circumflex artery was dissected free and instrumented with a Doppler flow probe (2.5 mm) and hydraulic occluder. Incisions were closed in layers and sterile dressings were applied. Postoperative prophylactic cephazolin (1 g im) was given twice per day for 2 days.Experimental Protocol
Animals were allowed to recover for 72 h after surgery. They were then subjected to the 4-day protocol of repetitive ischemia. Before each ischemic period, the animals were brought from the animal cage into the adjacent laboratory suite and sedated with xylazine (2 mg/kg im) and telazol (4 mg/kg im). They underwent 10 min of coronary artery occlusion with complete reperfusion. The Doppler coronary flow signal and the presence of electrocardiogram changes confirmed ischemia. Occlusion of the coronary artery was performed twice per day with 4 h of reperfusion between each ischemic period.Before the final episode of ischemia on the final day, animals were sedated, intubated, and anesthetized with isoflurane (1%). A PET scan was performed during the last period of ischemia, allowing spatial localization of the circumflex region at risk. Animals were then allowed to recover. Twenty-four hours later, the pigs were sedated, reintubated, and anesthetized with isoflurane (1%) for the terminal echocardiogram and PET studies.
Regional Wall Thickening
Two-dimensional echocardiograms were obtained (model 2500, Hewlett-Packard) from the right parasternal and apical views. Regional wall thickening was measured at the midparasternal short-axis view, and analyses were performed in the posterior (circumflex) and anterior (remote) walls. Wall thickening was computed as the difference between end-systolic and end-diastolic wall thicknesses and expressed as a percentage of end-diastolic thickness (Hewlett-Packard software program). End diastole and end systole were defined as the onset of the QRS and the frame with the smallest chamber size, respectively.Positron Emission Tomography Studies
After the animals were positioned on the PET imaging table, images were acquired with an ECAT 953B/31 (CTI/Siemens; Knoxville, TN). Myocardial blood flows were obtained with [13N]ammonia (15 mCi) infused intravenously over 20 s during acquisition of dynamic scans. The scanning protocol consisted of one 30-s, twelve 10-s, two 30-s, three 60-s, and one 900-s frame. During the final PET study, FDG (6 mCi) was infused for 50 min after the blood flow study and dynamic scans were acquired over the next 40 min. The FDG scanning protocol included twelve 10-s, six 30-s, four 60-s, three 120-s, three 300-s, and one 600-s frame. Arterial blood samples were obtained during the FDG scan, and plasma substrate levels were later analyzed by enzymatic techniques.Data Analysis of PET Images
For analysis of the studies, ~10 regions of interest (ROIs) were obtained from both the ischemic (circumflex) and nonischemic (remote) territories and saved for later analysis. A circular ROI was obtained from the largest portion of the LV cavity to serve as the arterial input. Time-activity curves for each ROI were obtained from the dynamic [13N]ammonia and FDG scans.Myocardial blood flow. For estimation of regional myocardial blood flow, we applied a three-compartment model (27). Myocardial blood flows were obtained by a nonlinear least-square fitting to the model equation using the input function and 18 tissue samples acquired in the first 6 min of the dynamic scan.
FDG uptake. Patlak plots were generated from the time-activity curves. Values were averaged for the circumflex and remote regions. The Patlak plot defines a constant (K), which incorporates the forward (k1) and reverse (k2) rate constants from plasma to tissue as well as the phosphorylation (k3) constant. The formula is expressed as K = (k1 × k2)/(k2 + k3). The dephosphorylation constant (k4) is assumed to be zero. The metabolic rates of glucose uptake were determined from arterial plasma glucose samples an assumed lumped constant of 0.67 (29).
Postmortem Analysis
After the final PET scan, animals were returned to the adjacent surgical suite for tissue extraction. To avoid hypotension during exposure of the heart, anesthesia was supplemented with
-chloralose
(150 mg/kg iv) while the isoflurane was weaned. A midline sternotomy
was then performed. During stable hemodynamics and within 30 min of the
final PET study, transmural biopsies were obtained from the circumflex
and remote regions using a modified variable high-speed dental drill.
The drill bit was capable of acquiring 100 mg of full-thickness
specimens, which were transferred to liquid nitrogen-cooled
2-methyl-butane within 1 s. They were then stored at
70°C
(24). Discrimination was not made between endocardial and
epicardial tissue and therefore subsequent analysis was expressed as
transmural tissue levels.
ATP and CP.
The tissue was extracted within 24 h in 7.1% perchloric acid,
homogenized, and centrifuged. The supernatant was neutralized (pH 7.2)
with 2 N KOH, 0.4 M imidazole, and 0.4 M KCl and centrifuged to remove
potassium perchlorate. Samples were stored at
70°C. ATP and CP were
assayed spectrophotometrically in a two-step coupled enzymatic system
with hexokinase and glucose-6-phosphate in which the reduction of
nicotinamide adenine dinucleotide phosphate (NADP) at E340
was followed.
GLUT content.
Samples were given a number code and analyzed for GLUT content without
knowledge of the sample origin. Membrane isolation, protein assays, and
immunoblotting of GLUTs were performed as previously described
(14). Antisera to the carboxyl-termini of rat GLUT-1 and
GLUT-4 elicited to the 13 and 18 COOH-terminal amino acid residues were
employed. Frozen tissue (30-50 mg) was homogenized (4 × 30 s), sonicated, and centrifuged (200,000 g at 4°C)
for 22 min. Membranes were subjected to sodium dodecyl sulfate-11%
polyacrylamide gel electrophoresis and the resolved proteins were
electrophoretically transferred to nitrocellulose. The blots were
blocked with 5% nonfat dried milk and probed with antibodies to the
GLUTs (1:1,000 dilution), and bound IgG detected horseradish
peroxidase-conjugated goat anti-rabbit IgG (1:10,000 dilution) as
required. Enhanced chemiluminescence detection was performed with X-ray
film. For detection of 125I on dried blots, a Bio-Rad
(Hercules, CA) phosphorimager or autoradiography with an intensifying
screen at
80°C were employed as necessary. Quantification of the
results was then performed. The crude membranes prepared from rat or
porcine brain tissue was used as internal standards for GLUT-1. Crude
membranes prepared from adipose tissue of rat epididymal fat pads or
porcine endometrial fat pads were used as internal standards for
GLUT-4. Relative GLUT levels in individual samples were determined from
phosphorimager intensities for the immunoreactive bands at
45-65,000 M using Molecular Analyst software (Bio-Rad).
Integration of the intensity of the immunoreactive bands for each
individual sample lane was employed and normalized between immunoblots
to the intensities of the appropriate internal standard.
Glycogen and glycogen synthase. For glycogen concentrations, tissue was dissolved in 30% KOH, precipitated with ethanol, and hydrolyzed using amyloglucosidase. The glucose residues were measured with an NADP-linked spectrophotometric method by use of glucose-6-phosphate dehydrogenase and hexokinase. For enzyme activities, frozen tissue was pulverized to a fine powder in a liquid nitrogen-cooled stainless steel percussion mortar. Tissue was then homogenized in 60% glycerol, 10 mM EDTA, and 50 mM KFl, pH 7.0, 1:2 (wt:vol) in a Potter-Elvehjem homogenizer. Homogenization was completed at 0°C using 10 mM EDTA and 50 mM KFl, pH 7.0, 1:10 (wt:vol). The homogenate was centrifuged at 12,000 g for 10 min at 4°C and the supernatant was used for assay. Glycogen synthase (GS) was assayed using the method of Thomas et al. (39). Units are micromoles of UDP [14C]glucose incorporated into glycogen per minute. Glycogen phosphorylase (GP) was assayed by the method of Gilboe et al. (10). Units are micromoles of [14C]G-1-P incorporated into glycogen per minute. Activities of synthase or phosphorylase are reported as the fraction of total activity present in the physiologically active forms, GS-I or GP type a (GPa).
Hexokinase activity. Frozen tissue was homogenized and hexokinase activity was estimated by determining the rate of NADP production measured over 20 min at 340 nm and 30°C.
Immunohistochemistry.
Transmural sections (5 µm) from frozen samples were cut on a cryostat
microtome, mounted on Superfrost Plus slides, air dried for 2 min, and
stored at
80°C. Slides were fixed in methanol at
20°C for 20 min, rehydrated with Tris-buffered saline (TBS), and blocked with 1%
bovine serum albumin (fraction V) and 0.5% Tween 20. For
colocalization of GLUT-4 with nuclei, slides were incubated for 2 h at 37°C with polyclonal rabbit GLUT-4 antisera, diluted 1:100, and
followed by a 1-h wash in TBS. Fluorescein-labeled donkey anti-rabbit
IgG and propidium iodide were used at a dilution of 1:50 and 1:200,
respectively, and the slides were incubated at 37°C for 1 h,
followed by a 1-h wash in TBS. For colocalization of hexokinase with
mitochondria, slides were incubated with a polyclonal anti-hexokinase
II antibody (Alpha Diagnostics; San Antonio, TX) and a monoclonal
anti-mitochondrial antibody (NeoMarkers; Fremont, CA). Sections were
washed and incubated with flourescein-labeled IgG I-150 and CY3-labeled
IgG I-150, followed by a brief wash. The slides were mounted with
Vectashield (Vector Labs) and examined with confocal microscopy.
Statistical Analysis
Results are expressed as means ± SD. Differences between the postischemic circumflex and remote regions were tested at the P < 0.05 level of significance with paired Student's t-test.| |
RESULTS |
|---|
|
|
|---|
Fifteen animals were used for these studies. One animal fibrillated during the final ischemic period in the PET suite and did not survive. Another animal died from an infection before completion of the protocol. Both animals are not included. Two pigs fibrillated on the first day of ischemia and were promptly cardioverted to sinus rhythm. They completed the protocol uneventfully and are included in the results.
Myocardial Blood Flow, Function, and Glucose Uptake
Twenty-four hours after the final episode of ischemia, regional myocardial blood flow and systolic wall thickening were similar in the circumflex and remote territories (Table 1). End-systolic and end-diastolic wall thickness in the remote region were 11.2 ± 1.8 mm and 8.9 ± 1.2 mm, respectively, whereas end-systolic and end-diastolic wall thickness in the circumflex region were 11.7 ± 2.5 mm and 9.1 ± 1.8 mm, respectively. There were no regional differences in transmural ATP, CP, or CP-to-ATP ratios (Table 2). Despite the absence of stunning, myocardial FDG uptake was significantly higher in the postischemic circumflex region compared with the remote region (Table 3; Fig. 1).
|
|
|
|
Glycogen Levels
Glycogen in the postischemic circumflex region was ~25% higher than in the remote region, with no regional differences detected in activities of either GS-I or phosphorylase (Table 4). When normalized to the remote region, the degree of increased glycogen within the postischemic circumflex region correlated well with the relative increase in FDG uptake within the same regions (r2 = 0.78; P < 0.001). This suggests that the increased rates of glucose transport and/or phosphorylation are important determinants of the relative accumulation of glycogen.
|
GLUT-4 and Hexokinase Activity
The content of GLUT-1 and GLUT-4 in the heart tissue samples was compared with that of membranes from the pig and rat brains and adipose tissues. The pig brain contained easily measurable quantities of ~50-kDa GLUT-1. However, the content of GLUT-1 in the pig heart samples was ~10% of brain tissue and near the limit of detection with our method. GLUT-4 of ~50 kDa was easily detected in all the pig heart membrane samples and was about twofold more abundant than in adipose membranes (Fig. 2). There was no difference in total membrane associated GLUT-4 content between the postischemic circumflex and remote regions. Hexokinase activity was significantly higher in the postischemic circumflex region compared with the remote territory (Fig. 3). Although quantitative differences in the degree of GLUT-4 translocation were not determined, qualitative estimates of regional difference in the degree of translocation by immunohistochemistry were not apparent (Fig. 4). Immunohistochemical staining of hexokinase showed that the activated form from the postischemic circumflex region was dispersed within the cytoplasm in the vicinity of the mitochondria, whereas the inactive form from the remote region was clumped in perinuclear areas (Fig. 5).
|
|
|
|
| |
DISCUSSION |
|---|
|
|
|---|
Several new observations are reported in this study. First, in a model of repetitive regional myocardial ischemia, abnormalities in glucose metabolism during fasting conditions persist at a time that mechanical and bioenergetic markers of stunning have recovered. Second, the degree of glycogen "overshoot" in this model correlates with the relative degree of increased FDG accumulation, suggesting that increased rates of glucose transport and/or phosphorylation are linked to increased glycogen levels in hearts subjected to repetitive bouts of ischemia. Third, the augmented glucose uptake 24 h after repetitive ischemia is associated with increased hexokinase activity.
Glucose Uptake and Reperfused Myocardium
Many animal studies utilizing a variety of techniques have characterized changes in myocardial substrate utilization after ischemia-reperfusion. Although glycolysis may play an important role in supporting some cellular functions during early reperfusion (9, 16), it is clear that the predominant substrate for overall energy expenditure remains fatty acids (20, 31). Within severely stunned myocardium, a sustained increase in glucose uptake has been observed at least 24 h after ischemia and signifies an increase in nonoxidative pathways (34). It is interesting that the increase in glucose uptake occurs at a time of incomplete recovery of glycogen, suggesting that reperfused myocardium shunts glucose away from glycogen synthesis and toward alternate energy-generating pathways (25). Glycogen turnover is a dynamic process in the heart and a small change in the rate of synthesis or degradation could impart a larger change in total glycogen accumulation (11). If glycolysis were slowed or unchanged after reperfusion, increased rates of glucose transport and/or phosphorylation would be important determinants of overall glycogen levels.Glucose Transport and Phosphorylation
Multiple episodes of ischemia-reperfusion could have a sustained effect on glucose transport and/or phosphorylation. Prolonged moderate ischemia provides a strong stimulus for translocation of GLUTs from cytoplasmic stores to active sites on the sarcolemma (41). The signal involved with this process acts independently of phosphatidylinositol-3 kinase or insulin-mediated mechanisms (36) and is likely dependent on cell signaling enzymes such as mitogen-activated protein kinases (MAPK), p38 MAPK, and MAPK-activated protein kinase-2 (40). Conversely, it might also involve activation of other kinases in response to ischemia, such as AMP-activated protein kinase (32). Whether intracellular translocation of GLUTs is a prerequisite for a sustained increased in glucose uptake post ischemia-reperfusion is not clear. In the present study, the degree of GLUT-4 translocation did not appear by immunohistochemistry to differ between the postischemic circumflex and remote regions 24 h after the final episode of ischemia. Although this was not a quantitative assessment of the degree of translocation, the findings support data from other models of reperfused myocardium, in which a sustained increase in glucose uptake was observed at a time that translocation of GLUTs was not evident (26). We also found no difference in GLUT-4 in this protocol of repetitive ischemia-reperfusion, which is consistent with another swine model of chronic ischemia involving a 4-day coronary artery stenosis (18). In the present study, we analyzed GLUT-1 content in all of the samples, with specific probes that showed a robust signal for rat and pig brain. The total content of GLUT-1 was <10% of the standards in all samples and, although clearly detectable, was beyond the limits of adequate quantitation. Previous studies (17) from rat cardiac myocytes have shown that GLUT-1 content is ~25% of that of GLUT-4 after a 5-h fast. After a 24-h fast, however, as was instituted in the present study, GLUT-1 was reduced by ~40%, whereas GLUT-4 content remained unaffected (17). Therefore, the explanation for low levels of GLUT-1 relative to GLUT-4 in the present study may reflect the intense fasting conditions. Ischemia has been shown to induce an upregulation in GLUT-1 mRNA expression within the heart (7), and it is possible that the metabolic state during the present study abolished significant differences in the protein after the repetitive ischemia protocol.Of interest, hexokinase activity was increased 24 h after the final episode of ischemia. Although this observation is new, it is not surprising, considering that hexokinase activity was shown (28) as both activated and expressed within skeletal muscle from rats undergoing vigorous exercise training. Although transport of glucose within myocardium plays a predominant role in the determination of overall glucose utilization, increased rates of phosphorylation may be important during various metabolic conditions (21). The immunohistochemical localization of hexokinase in its activated state was dispersed throughout the cytoplasm in the vicinity of the mitochondria. This is compatible with previous studies (33) that have provided evidence for compartmentalization of the active form of hexokinase within the cytoplasm compared with the inactive state, which is clumped in perinuclear locations. From the present study, it is difficult to determine the physiological significance of these sustained abnormalities in glycogen and hexokinase. However, the findings support the notion that a sustained metabolic imprint may be observed well after other indexes of stunning have normalized.
Effects of Repetitive Ischemia-Reperfusion
Although the length of time required for recovery of the glucose abnormalities is dependent upon the severity of the period of ischemia, metabolic markers of reperfusion injury return to normal in parallel with function within weeks of a severe episode of ischemia (3, 15, 23, 35). In models of repetitive ischemia-reperfusion, regional function normalizes earlier than after a single episode of ischemia as a result of "preconditioning against stunning" (37). As such, one would expect that functional recovery within models of repetitive stunning might precede recovery of other metabolic markers of reperfusion injury, such as the sustained increase in glucose uptake. In the present study, reperfused myocardium was studied within 24 h of the final ischemic episode. In pigs subjected to multiple episodes of ischemia-reperfusion, that period of time has been shown to be within the late window of preconditioning against stunning. During this time period, the elaboration of nitric oxide (NO) via increased expression of inducible NO synthase may account for early recovery of function after stunning (2). Although NO has been shown to alter substrate utilization by decreasing glucose uptake (30), activated p38 MAPK and MAPK-activated protein kinase-2 has been observed at this time (5) and might be expected to increase glucose transport (40). Whether overall fatty utilization is altered differently after repetitive ischemia-reperfusion compared with a single episode of ischemia is unclear (12).Limitations
In these studies, regional wall thickening was measured by echocardiogram rather than by piezoelectric crystals, because implantation of crystals could create an inflammatory reaction on the epicardial surface and confound the interpretation of the final FDG study. A two-dimensional echocardiogram has been deployed in PET-related studies (1, 4, 22) using a variety of chronically ischemic animal models. Although multiple estimates of regional function and glucose uptake during evolution of the model would have been informative, the primary focus was to correlate tissue levels of glycogen and hexokinase at the conclusion of the protocol, along with in vivo estimates of glucose uptake.Analogs of glucose such as deoxyglucose are transported and phosphorylated at different rates than glucose. Approximations have been made in the present study, which have been previously validated. However, it has been well described (13, 19) that the factor that corrects for differences in rates of transport between glucose and deoxyglucose may vary dependent upon substrate and insulin levels. To minimize this problem, we used fasted conditions, in which levels of insulin and glucose were low.
In conclusion, in this model of repetitive ischemia-reperfusion in swine, glucose uptake and glycogen storage are increased 24 h after the final ischemic period, at a time that functional and bioenergetic markers of stunning have recovered. The significant correlation between glycogen content and FDG accumulation in the postischemic region suggests that increased rates of glucose transport and/or phosphorylation are linked to increased glycogen levels in hearts subjected to repetitive bouts of ischemia.
| |
ACKNOWLEDGEMENTS |
|---|
This work was supported by a grant from the National Institutes of Health (to E. O. McFalls).
| |
FOOTNOTES |
|---|
Address for reprint requests and other correspondence: E. O. McFalls, Cardiology Dept., 111C, Veterans Affairs Medical Center, 1 Veterans Dr., Minneapolis, MN 55417 (E-mail: mcfal001{at}tc.umn.edu).
The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Received 5 July 2001; accepted in final form 26 September 2001.
| |
REFERENCES |
|---|
|
|
|---|
1.
Bergmann, SR,
Weinheimer CJ,
Brown MA,
and
Perez JE.
Enhancement of regional myocardial efficiency and peristence of perfusion, oxidative, and functional reserve with paired pacing of stunned myocardium.
Circulation
89:
2290-2296,
1994
2.
Bolli, R,
Manchikalapudi S,
Tang XL,
Takano H,
Qiu Y,
Guo Y,
Zhang Q,
and
Jadoon AK.
The protective effect of late preconditioning against myocardial stunning in conscious rabbits is mediated by nitric oxide synthase. Evidence that nitric oxide acts both as a trigger and as a mediator of the late phase of ischemic preconditioning.
Circ Res
81:
1094-1107,
1997
3.
Buxton, DB,
and
Schelbert HR.
Measurement of regional glucose metabolic rates in reperfused myocardium.
Am J Physiol Heart Circ Physiol
261:
H2058-H2068,
1991
4.
Buxton, DB,
Vaghaiwalla M,
Krivokapich J,
Phelps ME,
and
Schelbert HR.
Quantitative assessment of prolonged metabolic abnormalities in reperfused canine myocardium.
Circulation
85:
1842-1856,
1992
5.
Dana, A,
Skarli M,
Papakrivopoulou J,
and
Yellon D.
Adenosine A1 receptor induced delayed preconditioning in rabbits: Induction of p38 MAP kinase activation and Hsp27 phosphorylation via a tyrosine kinase and protein kinase C-dependent mechanism.
Circ Res
86:
989-997,
2000
6.
Depre, C,
Vanoverschelde J,
Melin J,
Borgers M,
Bol A,
Ausma J,
Dion R,
and
Wijns W.
Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans.
Am J Physiol Heart Circ Physiol
268:
H1265-H1275,
1995
7.
Egert, S,
Nguyen N,
and
Schwaiger M.
Contribution of alpha-adrenergic and beta-adrenergic stimulation to ischemia-induced glucose trasporter (GLUT) 4 and GLUT1 translocation in the isolated perfused rat heart.
Circ Res
84:
1407-1415,
1999
8.
Feldhaus, LM,
and
Liedtke AJ.
mRNA expression of glycolytic enzymes and glucose transporter proteins in ischemic myocardium with and without reperfusion.
J Mol Cell Cardiol
30:
2475-2485,
1998[ISI][Medline].
9.
Fralix, TA,
Steenbergen C,
London RE,
and
Murphy E.
Metabolic substrates can alter postischemic recovery in preconditioned ischemic heart.
Am J Physiol Cell Physiol
263:
C17-C23,
1992
10.
Gilboe, DP,
Larson KL,
and
Nuttall FQ.
A radioactive method for the assay of glycogen phosphorylases.
Anal Chem
47:
20-27,
1972.
11.
Goodwin, GW,
Arteaga JR,
and
Taegtmeyer H.
Glycogen turnover in the isolated working rat heart.
J Biol Chem
270:
9234-9240,
1995
12.
Hacker, TA,
Renstrom B,
Nellis SH,
and
Liedtke AJ.
Effect of repetitive stunning on myocardial metabolism in pig hearts.
Am J Physiol Heart Circ Physiol
273:
H1395-H1402,
1997
13.
Hariharan, R,
Bray M,
Ganim R,
Doenst T,
Med C,
Goodwin G,
and
Taegtmeyer H.
Fundamental limitations of [18F]2-deoxy-2-fluoro-D-glucose for assessing myocardial glucose uptake.
Circulation
91:
2435-2444,
1995
14.
Haspel, HC,
Rosenfeld MG,
and
Rosen OM.
Characterization of antisera to a synthetic carboxyl-terminal peptide of the glucose transporter protein.
J Biol Chem
263:
398-403,
1988
15.
Heyndrickx, GR,
Wijns W,
Vogelaers D,
Degrieck Y,
Bol A,
Vandeplassche G,
and
Melin J.
Recovery of regional contractile function and oxidative metabolism in stunned myocardium induced by 1-h circumflex coronary artery stenosis in chronically instrumented dogs.
Circ Res
72:
901-913,
1993
16.
Jeremy, RW,
Koretsune Y,
Marban E,
and
Becker LC.
Relation between glycolysis and calcium homeostasis in postischemic myocardium.
Circ Res
70:
1180-1190,
1992
17.
Kraegen, E,
Sowden J,
Halstead M,
Clark P,
Rodnick K,
Chisholm D,
and
James D.
Glucose transporters and in vivo glucose uptake in skeletal and cardiac muscle: fasting, insulin stimulation and immunoisolation studies of GLUT1 and GLUT4.
Biochem J
295:
287-293,
1993.
18.
Liedtke, AJ,
Brenstrom B,
Nellis SH,
Hall JL,
and
Stanley WC.
Mechanical and metabolic functions in pig hearts after 4 days of chronic coronary stenosis.
J Am Coll Cardiol
26:
815-825,
1995[Abstract].
19.
Liedtke, AJ,
Renstrom B,
and
Nellis SH.
Correlation between (5-3H) glucose and (U-14C) deoxyglucose as markers of glycolysis in reperfused myocardium.
Circ Res
71:
689-700,
1992
20.
Lopaschuk, GD,
Spafford MA,
Davies NJ,
and
Wall SR.
Glucose and palmitate oxidation in isolated working rat hearts reperfused after a period of transient global ischemia.
Circ Res
66:
546-553,
1990
21.
Manchester, J,
Kong X,
Nerbonne J,
Lowry O,
and
Lawrence J.
Glucose transport and phosphorylation in single cardiac myocytes: rate-limiting steps in glucose metabolism.
Am J Physiol Endocrinol Metab
266:
E326-E333,
1994
22.
McFalls, EO,
Baldwin D,
Palmer B,
Marx D,
Jaimes D,
and
Ward HB.
Regional glucose uptake within hypoperfused swine myocardium as measured by PET.
Am J Physiol Heart Circ Physiol
272:
H343-H349,
1997
23.
McFalls, EO,
Baldwin D,
Palmer B,
Marx D,
Jaimes D,
and
Ward HB.
Temporal changes in function and regional glucose uptake within stunned porcine myocardium.
J Nucl Med
37:
2006-2010,
1996
24.
McFalls, EO,
Baldwin DR,
Marx D,
Maxwell K,
and
Ward HB.
Glucose uptake increases relative to oxygen consumption during short-term hibernation.
Basic Res Cardiol
95:
39-46,
2000[ISI][Medline].
25.
McNulty, PH,
Jagasia D,
Cline G,
Ng C,
Whiting J,
Garg P,
Shulman G,
and
Soufer R.
Persistent changes in myocardial glucose metabolism in vivo during reperfusion of a limited-duration coronary occlusion.
Circulation
101:
917-922,
2000
26.
Montessuit, C,
Papageorgiou I,
Remondino-Muller A,
Tardy I,
and
Lerch R.
Postischemic stimulation of 2-deoxyglucose uptake in rat myocardium: role of translocation of GLUT-4.
J Mol Cell Cardiol
30:
393-403,
1998[ISI][Medline].
27.
Muzik, O,
Beanlands RSB,
Hutchins GD,
Mangner TJ,
Nguyen N,
and
Schwaiger M.
Validation of nitrogen-13-ammonia tracer kinetic model for quantification of myocardial blood flow using PET.
J Nucl Med
34:
83-91,
1993
28.
Nakatani, A,
Han D,
Hansen P,
Nolte L,
Host H,
Hickner R,
and
Holloszy J.
Effect of endurance exercise training on muscle glycogen supercompensation in rats.
J Appl Physiol
82:
711-715,
1997
29.
Ratib, O,
Phelps ME,
and
Huang SC.
Positron tomography with deoxyglucose for estimating local myocardial glucose metabolism.
J Nucl Med
23:
577-586,
1982
30.
Recchia, FA,
McConnell PI,
Loke KE,
Xu X,
Ochoa M,
and
Hintze TH.
Nitric oxide controls cardiac substrate utilization in the conscious dog.
Cardiovasc Res
44:
325-332,
1999
31.
Renstrom, B,
Nellis SH,
and
Liedtke AJ.
Metabolic oxidation of glucose during early myocardial reperfusion.
Circ Res
65:
1094-1101,
1989
32.
Russel, RR,
Bergeron R,
Shulman G,
and
Young L.
Translocation of myocardial GLUT-4 and increased glucose uptake through activation of AMPK by AICAR.
Am J Physiol Heart Circ Physiol
277:
H643-H649,
1999
33.
Russell, RR,
Mrus JM,
Mommessin JI,
and
Taegtmeyer H.
Compartmentation of hexokinase in rat heart: a critical factor for tracer kinetic analysis of myocardial glucose metabolism.
J Clin Invest
90:
1972-1977,
1992.
34.
Schwaiger, M,
Neese RA,
Araujo L,
Wyns W,
Wisneski JA,
Sochor H,
Swank S,
Kulber D,
Selin C,
Phelps M,
Schelbert HR,
and
Fishbein MC.
Sustained nonoxidative glucose utilization and depletion of glycogen in reperfused canine myocardium.
J Am Coll Cardiol
13:
745-754,
1989[Abstract].
35.
Schwaiger, M,
Schelbert HR,
Ellison D,
Hansen H,
Yeatman L,
Vinten-Johansen J,
Selin C,
Barrio J,
and
Phelps ME.
Sustained regional abnormalities in cardiac metabolism after transient ischemia in the chronic dog model.
J Am Coll Cardiol
6:
336-347,
1985[Abstract].
36.
Sun, D,
Nguyen N,
DeGrado T,
Schwaiger M,
and
Brosius FC.
Ischemia induces translocation of the insulin-responsive glucose transporter GLUT4 to the plasma membrane of cardiac myocytes.
Circulation
89:
793-798,
1994
37.
Tang, XL,
Qiu Y,
Park SW,
Sun J,
Kalya A,
and
Bolli R.
Time course of late preconditioning against myocardial stunning in conscious pigs.
Circ Res
79:
424-434,
1996
38.
Tardy-Cantalupi, I,
Montessuit C,
Papageorgiou I,
Remondion-Muller A,
Assimacopoulos-Jeannet F,
Morel D,
and
Lerch R.
Effect of transient ischemia on the expression of glucose transporters GLUT-1 and GLUT-4 in rat myocardium.
J Mol Cell Cardiol
31:
1143-1155,
1999[ISI][Medline].
39.
Thomas, JA,
Schlender KK,
and
Larner J.
A rapid filter paper assay for UDP glucose-glycogen glucosyltransferase, including an improved biosynthesis of UDP-14C-glucose.
Anal Biochem
25:
486-499,
1968[ISI][Medline].
40.
Tong, H,
Chen W,
London RE,
Murphy E,
and
Steenbergen C.
Preconditioning enhanced glucose uptake is mediated by p38 MAP kinase not by phosphatidylinositol 3-kinase.
J Biol Chem
275:
11981-11986,
2000
41.
Young, LH,
Rengu Y,
Russell R,
Hu X,
Caplan M,
Ren J,
Shulman GI,
and
Sinusas AJ.
Low-flow ischemia leads to translocation of canine heart GLUT4 and GLUT1 glucose transporters to the sarcolemma in vivo.
Circulation
95:
415-422,
1997
This article has been cited by other articles:
![]() |
T. Matsui, T. Nagoshi, E.-G. Hong, I. Luptak, K. Hartil, L. Li, N. Gorovits, M. J. Charron, J. K. Kim, R. Tian, et al. Effects of chronic Akt activation on glucose uptake in the heart Am J Physiol Endocrinol Metab, May 1, 2006; 290(5): E789 - E797. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Zhou, J. E. Salem, G. M. Saidel, W. C. Stanley, and M. E. Cabrera Mechanistic model of cardiac energy metabolism predicts localization of glycolysis to cytosolic subdomain during ischemia Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2400 - H2411. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, M. Hou, R. J. Bache, A. Best, D. Marx, J. Sikora, and H. B. Ward Activation of p38 MAPK and increased glucose transport in chronic hibernating swine myocardium Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1328 - H1334. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Gould, H. Taegtmeyer, Z.-X. He, R.-F. Shi, Y.-J. Wu, Y.-Q. Tian, X.-J. Liu, X.-W. Qin, R.-L. Gao, S.-W. Wang, et al. Myocardial Ischemia, Fluorodeoxyglucose, and Severity of Coronary Artery Stenosis: The Complexities of Metabolic Remodeling in Hibernating Myocardium * Response Circulation, March 30, 2004; 109(12): e167 - e170. [Full Text] [PDF] |
||||
![]() |
S.-J. Kim, A. Peppas, S.-K. Hong, G. Yang, Y. Huang, G. Diaz, J. Sadoshima, D. E. Vatner, and S. F. Vatner Persistent Stunning Induces Myocardial Hibernation and Protection: Flow/Function and Metabolic Mechanisms Circ. Res., June 13, 2003; 92(11): 1233 - 1239. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. O. McFalls, B. Murad, D. Her, J.-S. Liow, R. Kelly, D. Marx, J. Sikora, and H. B. Ward Repetitive Supply-Demand Ischemia with Dobutamine Increases Glucose Uptake in Postischemic and Remote Myocardium J. Nucl. Med., January 1, 2003; 44(1): 85 - 91. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |